journal
Journals Hepatology : Official Journal ...

Hepatology : Official Journal of the American Association for the Study of Liver Diseases

https://read.qxmd.com/read/37733267/canonical-wnt-signaling-promotes-hsc-glycolysis-and-liver-fibrosis-through-an-ldh-a-hif-1%C3%AE-transcriptional-complex
#1
JOURNAL ARTICLE
Feixia Wang, Li Chen, Desong Kong, Xiaojin Zhang, Siwei Xia, Baoyu Liang, Yang Li, Ya Zhou, Zili Zhang, Jiangjuan Shao, Shizhong Zheng, Feng Zhang
BACKGROUND AND AIMS: Aerobic glycolysis reprogramming occurs during HSC activation, but how it is initiated and sustained remains unknown. We investigated the mechanisms by which canonical Wnt signaling regulated HSC glycolysis and the therapeutic implication for liver fibrosis. APPROACH AND RESULTS: Glycolysis was examined in HSC-LX2 cells upon manipulation of Wnt/β-catenin signaling. Nuclear translocation of lactate dehydrogenase A (LDH-A) and its interaction with hypoxia-inducible factor-1α (HIF-1α) were investigated using molecular simulation and site-directed mutation assays...
September 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37733002/spatial-proteomics-of-immune-microenvironment-in-nonalcoholic-steatohepatitis-associated-hepatocellular-carcinoma
#2
JOURNAL ARTICLE
Meiyi Li, Lina Wang, Liang Cong, Chi Chun Wong, Xiang Zhang, Huarong Chen, Tao Zeng, Bin Li, Xian Jia, Jihui Huo, Yuhua Huang, Xiaoxue Ren, Sui Peng, Guo Fu, Lixia Xu, Joseph Jy Sung, Ming Kuang, Xiaoxing Li, Jun Yu
BACKGROUND AND AIMS: NASH-HCC is inherently resistant to immune checkpoint blockade, but its tumor immune microenvironment is largely unknown. APPROACH AND RESULTS: We applied the imaging mass cytometry to construct a spatially resolved single-cell atlas from the formalin-fixed and paraffin-embedded tissue sections from patients with NASH-HCC, virus-HCC (HBV-HCC and HCV-HCC), and healthy donors. Based on 35 biomarkers, over 750,000 individual cells were categorized into 13 distinct cell types, together with the expression of key immune functional markers...
September 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37732990/a-randomized-double-blind-placebo-controlled-trial-of-aldafermin-in-patients-with-nonalcoholic-steatohepatitis-and-compensated-cirrhosis
#3
JOURNAL ARTICLE
Mary E Rinella, Hsiao D Lieu, Kris V Kowdley, Zachary D Goodman, Naim Alkhouri, Eric Lawitz, Vlad Ratziu, Manal F Abdelmalek, Vincent Wai-Sun Wong, Ziad H Younes, Aasim M Sheikh, Donald Brannan, Bradley Freilich, Fernando Membreno, Marie Sinclair, Liza Melchor-Khan, Arun J Sanyal, Lei Ling, Stephen A Harrison
BACKGROUND AND AIMS: Aldafermin, an engineered analog of the human hormone FGF19, improves liver histology in patients with non-cirrhotic nonalcoholic steatohepatitis (NASH), however, its efficacy and safety in compensated cirrhosis is unknown. No drug has yet to demonstrate benefit in the compensated NASH population. APPROACH AND RESULTS: In this multicenter, double-blind, placebo-controlled, phase 2b trial, 160 patients with compensated NASH cirrhosis were randomized to aldafermin 0...
September 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37732952/physiologic-changes-in-the-hepatopulmonary-syndrome-before-and-after-liver-transplant-a-longitudinal-and-predictor-analysis
#4
JOURNAL ARTICLE
Xun Zhao, Sreelakshmi Kotha, Dhruv Nayyar, Xiayi Ma, Leslie Lilly, Hélène Castel, Samir Gupta
BACKGROUND AND AIMS: Hepatopulmonary syndrome (HPS) is a common complication of liver disease defined by abnormal oxygenation and intrapulmonary vascular dilatation, treated with liver transplantation. Little is known about changes in HPS physiological parameters over time. We sought to describe baseline clinical and physiological characteristics in HPS and their relationships, temporal changes in physiological parameters before and after transplant, and predictors of changes in oxygenation...
September 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37732946/national-prevalence-estimates-for-steatotic-liver-disease-and-sub-classifications-using-consensus-nomenclature
#5
JOURNAL ARTICLE
Brian P Lee, Jennifer L Dodge, Norah A Terrault
BACKGROUND AIMS: The multisociety consensus nomenclature has renamed non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD) with various sub-classifications. There is paucity of data regarding how the new nomenclature modifies our understanding of disease prevalence and patient phenotypes. APPROACH RESULTS: Using the National Health and Nutrition Examination Survey from 1/2017-3/2020, we included all participants aged≥18 with complete vibration-controlled transient elastography measures...
September 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37729391/computational-drug-prediction-in-hepatoblastoma-by-integrating-pan-cancer-transcriptomics-with-pharmacological-response
#6
JOURNAL ARTICLE
Mario Failli, Salih Demir, Álvaro Del Río-Álvarez, Juan Carrillo-Reixach, Laura Royo, Montserrat Domingo-Sàbat, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Sophie Branchereau, Stefano Cairo, Roland Kappler, Carolina Armengol, Diego di Bernardo
Hepatoblastoma (HB) is the main paediatric liver cancer, but it is a very rare disease. Despite significant improvements in the treatment of children diagnosed with HB, limited treatment options exist for patients with advanced tumours. Besides, survivors generally have long-term adverse effects derived from treatment such as ototoxicity, cardiotoxicity, delayed growth, and secondary tumours. Accordingly, there is an urgent need to define new and efficient therapeutic strategies for patients with HB. Computational methods to predict drug sensitivity from a tumour's transcriptome have been successfully applied for some common adult malignancies, but specific efforts in paediatric cancers are lacking because of paucity of data...
September 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37732945/telomere-length-and-risk-of-cirrhosis-hepatocellular-carcinoma-and-cholangiocarcinoma-in-63-272-individuals-from-the-general-population
#7
JOURNAL ARTICLE
Helene Gellert-Kristensen, Stig E Bojesen, Anne Tybjærg-Hansen, Stefan Stender
BACKGROUND AIMS: Inherited short telomeres are associated with risk of liver disease, whereas longer telomeres predispose to cancer. The association between telomere length and risk of hepatocellular carcinoma and cholangiocarcinoma remains unknown. APPROACH RESULTS: We measured leukocyte telomere length using multiplex PCR in 63,272 individuals from the Danish general population. Telomere length and plasma alanine transaminase concentration were not associated (β = 4 ×10⁻⁶, p-value = 0...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725765/letter-to-editor-nafld-improves-risk-prediction-of-type-2-diabetes-with-effect-modification-by-sex-and-menopausal-status
#8
JOURNAL ARTICLE
Mubashra Khalid, Zoraiz Munir Khan, Ahmad Sheraz Kahloon
No abstract text is available yet for this article.
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725764/reply-nafld-improves-risk-prediction-of-type-2-diabetes-with-effect-modification-by-sex-and-menopausal-status
#9
JOURNAL ARTICLE
Yejin Kim, Yoosoo Chang, Seungho Ryu, Sarah H Wild, Christopher D Byrne
No abstract text is available yet for this article.
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725761/obesity-management-for-the-hepatologist-what-to-do-how-to-do-it-and-why
#10
JOURNAL ARTICLE
Kymberly D Watt, Sonali Paul, Mohammad Qasim Khan, Mohammad Siddiqui, Jenny Lam, Tayyab S Diwan, Michael Camilleri
Obesity is highly prevalent in hepatology clinics and has significant impact in chronic liver disease and patient management. Hepatologists and gastroenterologist need to be actively engaged in the management of obesity. This review provides a detailed approach to this challenging comorbidity.
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725757/rna-nanomedicine-in-liver-diseases
#11
JOURNAL ARTICLE
Anita Bakrania, Yulin Mo, Gang Zheng, Mamatha Bhat
The remarkable impact of RNA nanomedicine during the COVID-19 pandemic has demonstrated the expansive therapeutic potential of this field in diverse disease contexts. In recent years, RNA nanomedicine targeting the liver has been paradigm-shifting in the management of metabolic diseases such as hyperoxaluria and amyloidosis. RNA nanomedicine has significant potential in the management of liver diseases, where optimal management would benefit from targeted delivery, doses titrated to liver metabolism, and personalized therapy based on the specific site of interest...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725755/hypoxia-driven-tumor-stromal-remodeling-and-immunosuppressive-microenvironment-in-scirrhous-hepatocellular-carcinoma
#12
JOURNAL ARTICLE
Shuling Chen, Changyi Liao, Huanjing Hu, Junbin Liao, Zebin Chen, Shuang Li, Xuezhen Zeng, Bo Peng, Shunli Shen, Dongming Li, Shaoqiang Li, Jiaming Lai, Sui Peng, Yubin Xie, Ming Kuang
BACKGROUND AND AIMS: Scirrhous hepatocellular carcinoma (SHCC) is one of the unique subtypes of hepatocellular carcinoma (HCC), characterized by abundant fibrous stroma in tumor microenvironment. However, it remains unclear about the molecular traits of SHCC, which is essential to develop specialized therapeutic approaches for SHCC. APPROACH RESULTS: We presented an integrative analysis containing single-cell RNA-sequencing, whole-exome sequencing, and bulk RNA-sequencing in SHCC and usual HCC samples from 134 patients, to delineate genomic features, transcriptomic profiles, and stromal immune microenvironment of SHCC...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725754/bile-acid-induced-irf3-phosphorylation-mediates-cell-death-inflammatory-responses-and-fibrosis-in-cholestasis-induced-liver-and-kidney-injury-via-regulation-of-zbp1
#13
JOURNAL ARTICLE
Yuan Zhuang, Martí Ortega-Ribera, Prashanth Thevkar Nagesh, Radhika Joshi, Huihui Huang, Yanbo Wang, Adam Zivny, Jeeval Mehta, Samir M Parikh, Gyongyi Szabo
Cell death and inflammation play critical roles in chronic tissue damage caused by cholestatic liver injury leading to fibrosis and cirrhosis. Liver cirrhosis is often associated with kidney damage that is a severe complication with poor prognosis. Interferon regulatory factor 3 (IRF3) is known to regulate apoptosis and inflammation, but its role in cholestasis remains obscure. In this study, we discovered increased IRF3 phosphorylation (p-IRF3) in the liver of patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725716/spatial-proximity-of-tumor-immune-interactions-predicts-patient-outcome-in-hepatocellular-carcinoma
#14
JOURNAL ARTICLE
Evan Maestri, Noemi Kedei, Subreen Khatib, Marshonna Forgues, Kris Ylaya, Stephen M Hewitt, Limin Wang, Jittiporn Chaisaingmongkol, Mathuros Ruchirawat, Lichun Ma, Xin Wei Wang
BACKGROUND AND AIMS: The fitness and viability of a tumor ecosystem are influenced by the spatial organization of its cells. We aimed to study the structure, architecture, and cell-cell dynamics of the heterogenous liver cancer tumor microenvironment using spatially resolved multiplexed imaging. APPROACH AND RESULTS: We performed co-detection by indexing (CODEX) multiplexed immunofluorescence imaging on 68 hepatocellular carcinoma (HCC) biopsies from Thai patients (TIGER-LC) as a discovery cohort, and then validated the results in an additional 190 HCC biopsies from Chinese patients (LCI)...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725713/higher-need-for-polycystic-liver-disease-therapy-in-female-patients-sex-specific-association-between-liver-volume-and-need-for-therapy
#15
JOURNAL ARTICLE
Thijs R M Barten, Femke Atsma, Adriaan J van der Meer, Ron Gansevoort, Frederik Nevens, Joost P H Drenth, Tom J G Gevers
BACKGROUND AIM: Prognostic tools or biomarkers are urgently needed in polycystic liver disease (PLD) to monitor disease progression and evaluate treatment outcomes. Total liver volume (TLV) is currently used to assess cross-sectional disease severity and female patients typically have larger livers than males. Therefore, this study explores the sex-specific association between TLV and volume reducing therapy. APPROACH RESULTS: In this prospective cohort study, we included PLD patients from European treatment centers...
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37725712/scirrhous-hcc-another-omic-thread-in-the-hcc-tapestry
#16
JOURNAL ARTICLE
Joseph W Franses, Dan G Duda
No abstract text is available yet for this article.
September 19, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37722133/it-could-happen-in-your-backyard
#17
JOURNAL ARTICLE
Mario Strazzabosco
No abstract text is available yet for this article.
September 18, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37722132/ceus-for-hcc-finally-out-from-the-waiting-list
#18
JOURNAL ARTICLE
Richard G Barr, Luigi Bolondi
No abstract text is available yet for this article.
September 18, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37722131/the-clinical-imperative-of-a-complete-biochemical-response-to-immunosuppression-in-autoimmune-hepatitis-close-is-not-good-enough
#19
JOURNAL ARTICLE
George Cholankeril, John M Vierling
No abstract text is available yet for this article.
September 18, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/37707477/december-2023-hepatology-highlights
#20
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 14, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
journal
journal
28566
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.